{
  "emaEpar": [],
  "fdaDrugLabel": [],
  "id": "Estramustine",
  "nciThesaurus": {
    "casRegistry": "2998-57-4",
    "chebiId": "CHEBI:4868",
    "chemicalFormula": "C23H31Cl2NO3",
    "definition": "A synthetic molecule combining estradiol and nornitrogen mustard through a carbamate link. Estramustine and its major metabolite estramustine bind to microtubule-associated proteins (MAPs) and tubulin, thereby inhibiting microtubule dynamics and leading to anaphase arrest in a dose-dependent fashion. This agent also exhibits anti-androgenic effects.",
    "fdaUniiCode": "35LT29625A",
    "identifier": "C479",
    "preferredName": "Estramustine",
    "semanticType": "Organic Chemical",
    "subclassOf": [
      "C25974",
      "C697"
    ],
    "synonyms": [
      "17beta-(estra-1,3,5(10)-triene-3,17-diol 3-(bis(2-chloroethyl)carbamate))",
      "ESTRAMUSTINE",
      "Estradiol 3-[bis(2-chloroethyl)carbamate]",
      "Estramustine",
      "Leo 275",
      "RO 21-8837",
      "estra-1,3,5(10)triene-317beta-diol 3-[N,N-bis-(2-chloroethyl)carbamate]",
      "estradiol 3-bis(2-chloroethyl)carbamate",
      "estramustine"
    ]
  }
}